Expression of Caspase-3 and-7 Does Not Correlate with the Extent of Apoptosis in Primary Breast Carcinomas

被引:25
作者
Grigoriev, Maxim Y. [1 ,2 ]
Pozharissky, Kazymir M. [1 ]
Hanson, Kaido P. [1 ]
Imyanitov, Evgeny N. [1 ]
Zhivotovsky, Boris [2 ]
机构
[1] NN Petrov Inst Oncol, St Petersburg 197758, Russia
[2] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden
关键词
Caspase-3; Caspase-7; Bcl-2; Breast carcinoma;
D O I
10.4161/cc.1.5.152
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Association between the rate of apoptosis and expression of the several relevant molecules (Bcl-2, pro-and active caspase-3, and caspase-7) was studied in 61 primary breast carcinomas. The rate of apoptosis detected both morphologically and by the TUNEL assay appeared to be high in 18 (30%), moderate in 14 (23%), and low in 29 (48%) carcinomas. High apoptotic index was strongly associated with advanced tumor grade and estrogen receptor positive (ER+) status but not with other investigated clinical or morphological parameters. Among the molecules studied, only the Bcl-2 protein expression demonstrated strong (inverse) correlation with the apoptotic index (p = 0.032). The data of this expected correlation was served as internal control in the study. Interestingly, high levels of the anti-apoptotic protein Bcl-2 was frequently co-incident with increased expression of pro-apoptotic molecules, such as active caspase-3 (p = 0.004) and caspase-7 (p = 0.001). However, expression of caspase-3 or caspase-7 did not show correlation with the extent of apoptosis or any clinico-morphological features, except overrepresentation of ER+ status in tumors expressing caspase-3 (p = 0.009). Thus, these findings indicate a general dysregulation of spontaneous apoptosis in primary breast tumors.
引用
收藏
页码:337 / 342
页数:6
相关论文
共 48 条
[21]  
Koomägi R, 2000, ANTICANCER RES, V20, P493
[22]   Prognostic significance of apoptosis regulators in breast cancer [J].
Krajewski, S ;
Krajewska, M ;
Turner, BC ;
Pratt, C ;
Howard, B ;
Zapata, JM ;
Frenkel, V ;
Robertson, S ;
Ionov, Y ;
Yamamoto, H ;
Perucho, M ;
Takayama, S ;
Reed, JC .
ENDOCRINE-RELATED CANCER, 1999, 6 (01) :29-40
[23]   APOPTOSIS IN BREAST-CANCER AS RELATED TO HISTOPATHOLOGICAL CHARACTERISTICS AND PROGNOSIS [J].
LIPPONEN, P ;
AALTOMAA, S ;
KOSMA, VM ;
SYRJANEN, K .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (14) :2068-2073
[24]   Apoptosis in breast cancer: relationship with other pathological parameters [J].
Lipponen, P .
ENDOCRINE-RELATED CANCER, 1999, 6 (01) :13-16
[25]   Caspases:: more than just killers? [J].
Los, M ;
Stroh, C ;
Jänicke, RU ;
Engels, IH ;
Schulze-Osthoff, K .
TRENDS IN IMMUNOLOGY, 2001, 22 (01) :31-34
[26]  
Nakagawara A, 1997, CANCER RES, V57, P4578
[27]   Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma [J].
O'Neill, AJ ;
Boran, SA ;
O'Keane, C ;
Coffey, RNT ;
Hegarty, NJ ;
Hegarty, P ;
Gaffney, EF ;
Fitzpatrick, JM ;
Watson, RWG .
PROSTATE, 2001, 47 (03) :183-188
[28]   The pattern of CPP32/caspase-3 expression reflects the biological behavior of the human pancreatic duct cell tumors [J].
Satoh, K ;
Kaneko, K ;
Hirota, M ;
Toyota, T ;
Shimosegawa, T .
PANCREAS, 2000, 21 (04) :352-357
[29]  
Shinoura N, 1999, CANCER RES, V59, P4119
[30]   Caspase-3/CPP32 immunoreactivity and its correlation with frequency of apoptotic bodies in human prostatic carcinomas and benign nodular hyperplasias [J].
Sohn, JH ;
Kim, DH ;
Choi, NG ;
Park, YE ;
Ro, JY .
HISTOPATHOLOGY, 2000, 37 (06) :555-560